BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3496053)

  • 1. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
    Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of gastric cancer completely responding to sequential methotrexate and 5-fluorouracil therapy].
    Ono M; Ishikawa H; Suzuki N; Miura T; Kaga S; Kano A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2035-8. PubMed ID: 8085854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advanced gastric carcinoma with extensive lymph node metastases successfully treated by sequential methotrexate/5-fluorouracil therapy].
    Adachi Y; Matsukuma A; Sakino I; Konishi J; Funahashi S; Yo R; Iso Y; Ayabe K; Moriyama M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1107-10. PubMed ID: 7611763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
    Iwamoto S; Kimoto M; Mure T; Onuma E; Yamamoto Y; Iki K; Yoshida K; Tadaoka Y; Majima T; Kawasaki S; Kubozoe T; Tsunoda T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):541-6. PubMed ID: 9530360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancer.
    Kinoshita K; Yonemura Y; Sawa T; Miyata T; Sakuma H; Matsuki N; Tanaka S; Fushida S; Fujimura T; Mok YJ; Kim BS; Lee JI; Choi DW; Song YJ; Yang DH; Kwon SJ; Tanaka M; Miyazaki I
    Hepatogastroenterology; 2003; 50(53):1716-9. PubMed ID: 14571825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
    Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intra-aortic infusion therapy with sequential methotrexate (MTX) and 5-FU in advanced gastric carcinoma].
    Kitamura M; Awane Y; Konishi T; Suzuki T; Arai K; Kosaki G; Sasaki T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1927-33. PubMed ID: 3486635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients.
    De Vita F; Orditura M; Auriemma A; Infusino S; Catalano G
    Panminerva Med; 1999 Mar; 41(1):35-8. PubMed ID: 10230255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leucovorin.5-FU therapy for advanced gastric cancer as a neoadjuvant chemotherapy].
    Kitamura M; Arai K; Iwasaki Y; Sasaki T; Maeda Y; Kobayashi T
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2115-7. PubMed ID: 8607625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of synergism and clinical results of sequential methotrexate and 5-fluorouracil in the treatment of gastric cancer].
    Konishi T; Hirata T; Miyama T; Hiraishi M; Mafune K; Yoshida J; Mori K; Nishina H; Idezuki Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):946-53. PubMed ID: 1626950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of preoperative FPL (5-fluorouracil, cisplatin, leucovorin) therapy on patients with primary unresectable advanced gastric cancer].
    Tsujinaka T; Kato T; Shiozaki H; Murata A; Nishijima J; Kobayashi K; Inoue M; Miyata M; Kido Y; Mori T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):303-6. PubMed ID: 8434971
    [No Abstract]   [Full Text] [Related]  

  • 13. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].
    Yamamura Y; Kodera Y; Kito T
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879
    [No Abstract]   [Full Text] [Related]  

  • 14. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose methotrexate and sequential 5-FU treatment in advanced gastric cancer].
    Sasaki T; Ibuka T; Imai K; Sakai Y; Ishiwata J; Satomi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2408-13. PubMed ID: 6497399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical modulation--the historical background].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):941-5. PubMed ID: 1626949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
    Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y
    Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.